{"References": [{"title": "Next-generation estrogen receptor-targeted therapeutics", "authors": "Jason S. Carroll, Myles Brown", "journal": "Nature Reviews Cancer", "year": "2012", "volumes": "12", "first page": "381", "last page": "388", "DOI": "10.1038/nrc3263"}, {"title": "The evolving role of the estrogen receptor mutations in endocrine therapy-resistant breast cancer", "authors": "Sarat Chandarlapaty, Arul M. Chinnaiyan", "journal": "Current Oncology Reports", "year": "2017", "volumes": "19", "first page": "35", "last page": "", "DOI": "10.1007/s11912-017-0591-8"}, {"title": "Selective estrogen receptor modulators (SERMs) and selective estrogen receptor degraders (SERDs) in cancer treatment", "authors": "V. Craig Jordan, Suzanne A. W. Fuqua", "journal": "Pharmacology & Therapeutics", "year": "2018", "volumes": "186", "first page": "1", "last page": "24", "DOI": "10.1016/j.pharmthera.2017.12.012"}, {"title": "The discovery and development of selective estrogen receptor modulators (SERMs) for clinical practice", "authors": "V. Craig Jordan, Barrington J. A. Furr", "journal": "Current Clinical Pharmacology", "year": "2010", "volumes": "5", "first page": "67", "last page": "72", "DOI": "10.2174/157488410790410579"}, {"title": "Mechanisms of resistance to estrogen receptor modulators in ER+ breast cancer", "authors": "Rachel Schiff, C. Kent Osborne", "journal": "Breast Cancer Research and Treatment", "year": "2005", "volumes": "92", "first page": "S101", "last page": "", "DOI": "10.1007/s10549-005-9059-x"}, {"title": "Development of selective estrogen receptor modulators (SERMs)", "authors": "John A. Katzenellenbogen, Benita S. Katzenellenbogen", "journal": "Science", "year": "1996", "volumes": "274", "first page": "1801", "last page": "1807", "DOI": "10.1126/science.274.5294.1801"}, {"title": "The role of selective estrogen receptor modulators (SERMs) in the prevention of breast cancer", "authors": "Victor G. Vogel, Joseph P. Costantino", "journal": "Breast Cancer Research and Treatment", "year": "2003", "volumes": "79", "first page": "S7", "last page": "S12", "DOI": "10.1023/A:1024339917227"}, {"title": "Selective estrogen receptor degraders (SERDs): A promising strategy for estrogen receptor positive endocrine-resistant breast cancer", "authors": "Suzanne A. W. Fuqua, V. Craig Jordan", "journal": "Journal of Medicinal Chemistry", "year": "2017", "volumes": "60", "first page": "8321", "last page": "8341", "DOI": "10.1021/acs.jmedchem.7b00165"}, {"title": "Emerging therapeutic agents for estrogen receptor-positive breast cancer", "authors": "Angela DeMichele, Maura N. Dickler", "journal": "Journal of Clinical Oncology", "year": "2016", "volumes": "34", "first page": "2465", "last page": "2472", "DOI": "10.1200/JCO.2015.65.3154"}, {"title": "The role of estrogen receptor mutations in tamoxifen-stimulated breast cancer", "authors": "Adrian V. Lee, Steffi Oesterreich", "journal": "Journal of Steroid Biochemistry and Molecular Biology", "year": "2001", "volumes": "76", "first page": "71", "last page": "77", "DOI": "10.1016/S0960-0760(00)00193-0"}]}